MET and breast cancer: Similarly, the effect of Fosl1 ablation can be analyzed in breast cancer-prone genetic backgrounds exhibiting mammary gland-specific expression of the Cre recombinase (e.g., MMTV-MET; MMTV-Cre; Trp53fl/+).